Pyrax Health Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -33.76%
- Profit Growth -170.55%
- Ebitda -163.47%
- Net Worth -84.92%
- Total Assets 7.19%
About Pyrax Health Sciences
Pyrax Health Sciences Private Limited (PHSPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 August 2019 (Five years and six months 1 days old ). Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Abhishek Gupta, Karunesh Gupta, Anurag Gupta, and Three other members serve as directors at the Company.
Company Details
-
Location
Haridwar, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24297UR2019PTC010051
-
Company No.
010051
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Aug 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Pyrax Health Sciences?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinayak Gupta
|
Director | 11-Nov-2019 | Current |
|
Karunesh Gupta
|
Director | 02-Aug-2019 | Current |
|
Abhishek Gupta
|
Director | 02-Aug-2019 | Current |
|
Anurag Gupta
|
Director | 02-Aug-2019 | Current |
|
Bharat Gupta
|
Director | 11-Nov-2019 | Current |
|
Sunita Gupta
|
Director | 11-Nov-2019 | Current |
Financial Performance of Pyrax Health Sciences.
Pyrax Health Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 33.76% decrease. The company also saw a substantial fall in profitability, with a 170.55% decrease in profit. The company's net worth observed a substantial decline by a decrease of 84.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pyrax Health Sciences?
In 2022, Pyrax Health Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Pyrax Polymars Private LimitedBharat Gupta and Vinayak Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pyrax Health Sciences?
Pyrax Health Sciences has a workforce of 7 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pyrax Health Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pyrax Health Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.